Bayesian Capital Management LP Takes $142,000 Position in Clover Health Investments, Corp. (NASDAQ:CLOV)

Bayesian Capital Management LP purchased a new stake in shares of Clover Health Investments, Corp. (NASDAQ:CLOV) in the 1st quarter, Holdings Channel.com reports. The institutional investor purchased 179,000 shares of the company’s stock, valued at approximately $142,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Jupiter Asset Management Ltd. grew its stake in shares of Clover Health Investments by 18.1% during the 1st quarter. Jupiter Asset Management Ltd. now owns 4,525,079 shares of the company’s stock valued at $3,593,000 after purchasing an additional 692,878 shares during the period. Jump Financial LLC purchased a new position in shares of Clover Health Investments during the 4th quarter valued at about $125,000. Turtle Creek Wealth Advisors LLC purchased a new position in Clover Health Investments in the 4th quarter worth approximately $162,000. SignalPoint Asset Management LLC lifted its holdings in Clover Health Investments by 40.3% in the 1st quarter. SignalPoint Asset Management LLC now owns 139,366 shares of the company’s stock worth $111,000 after purchasing an additional 40,000 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its holdings in Clover Health Investments by 151.2% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 77,948 shares of the company’s stock worth $62,000 after purchasing an additional 46,912 shares in the last quarter. 19.77% of the stock is currently owned by institutional investors.

Clover Health Investments Price Performance

NASDAQ CLOV opened at $1.80 on Friday. The stock’s 50 day moving average is $1.33 and its 200 day moving average is $1.01. Clover Health Investments, Corp. has a 12 month low of $0.61 and a 12 month high of $1.97.

Clover Health Investments (NASDAQ:CLOV) last released its quarterly earnings data on Tuesday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.02. Clover Health Investments had a negative return on equity of 48.07% and a negative net margin of 8.63%. The business had revenue of $346.92 million for the quarter, compared to the consensus estimate of $316.10 million. As a group, equities research analysts expect that Clover Health Investments, Corp. will post -0.21 earnings per share for the current fiscal year.

Clover Health Investments Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.